印度的2026-27年预算削减了关键药品的进口税,降低了个人进口税,并提高了对金融交易和奢侈品的税收。 India's 2026-27 budget cuts import duties on key medicines, lowers personal import taxes, and raises taxes on financial trades and luxury goods.

《2026-27年联邦预算》引入了有针对性的减税措施,减少了17种癌症和关键疾病药物的基本关税,扩大了7种罕见疾病所用药物的免税进口。 The Union Budget 2026-27 introduces targeted tax cuts, reducing basic customs duty on 17 cancer and critical illness drugs and expanding duty-free imports for medicines used in seven rare diseases. 货物的个人进口税从20%降低到10%,而海外旅游和教育汇款的TCS则下降至2%。 Personal import duties on goods are lowered from 20% to 10%, while TCS on overseas tourism and education remittances drops to 2%. 豁免适用于太阳玻璃成分、民用飞机零部件、微波炉和核电项目部件。 Duty exemptions extend to solar glass ingredients, civilian aircraft parts, microwave ovens, and nuclear power project components. 反之,期货和期权证券交易税升至0.05%和0.15%,对误报税款的处罚升至应缴税款的100%。 Conversely, Securities Transaction Tax on futures and options rises to 0.05% and 0.15%, and penalties for tax misreporting increase to 100% of the tax due. 一些奢侈品和烟草产品预计将变得更贵。 Some luxury goods and tobacco products are expected to become more expensive.